Skip to main content
PCI Biotech Holding logo

PCI Biotech Holding — Investor Relations & Filings

Ticker · PCIB ISIN · NO0010405640 LEI · 5967007LIEEXZXFIGG77 OL Manufacturing
Open in API
Filings indexed 752 across all filing types
Latest filing 2010-05-25 Share Issue/Capital Cha…
Country NO Norway
Listing OL PCIB

About PCI Biotech Holding

https://www.pcibiotech.no/

PCI Biotech Holding is a biopharmaceutical company developing therapeutic products based on its proprietary Photochemical Internalization (PCI) technology. This platform is a drug and nucleic acid delivery system designed to enhance the intracellular delivery of therapeutic molecules. The company's development programs are focused on applications in immunotherapy, dermatology, and bioprocessing for the manufacturing of viral vectors. A primary therapeutic area for the technology is cancer, where it aims to improve the efficacy of novel and existing treatments.

Recent filings

Filing Released Lang Actions
Tegningsrettene i PCI Biotech Holding ASA vil bli notert fra og med i morgen, 26.05.2010
Share Issue/Capital Change Classification · 95% confidence The document provides specific details regarding the listing of subscription rights (tegningsretter) for PCI Biotech Holding ASA, including the ticker, ISIN, subscription price, and subscription period. This constitutes an announcement of a capital change or share-related instrument issuance, which falls under the category of share issues or capital changes.
2010-05-25 Norwegian
Approved prospectus
Capital/Financing Update Classification · 95% confidence The document announces the approval of a prospectus for a rights offering of shares. It details the subscription period, the number of shares, and where the prospectus can be obtained. Since it describes a new share issuance and capital raising activity, it falls under the category of share issues and capital changes.
2010-05-25 English
Godkjent prospekt
Share Issue/Capital Change Classification · 95% confidence The document announces the approval of a prospectus by the Financial Supervisory Authority of Norway (Finanstilsynet) regarding a rights issue (fortrinnsrettsemisjon) of shares. It details the subscription period, the number of shares, and where the prospectus can be accessed. Since it is an announcement regarding the publication and availability of a prospectus for a capital raise, it falls under the category of a share issue/capital change announcement.
2010-05-25 Norwegian
Ex subscription rights - PCI Biotech Holding ASA
Share Issue/Capital Change Classification · 95% confidence The document is a short announcement (203 characters) stating that shares will be traded 'ex subscription rights'. This relates to a change in capital structure or share status, which falls under the category of share issues or capital changes.
2010-05-19 English
Eks tegningsretter - PCI Biotech Holding ASA
Share Issue/Capital Change Classification · 95% confidence The document is a very short notification (168 characters) informing shareholders that the company's shares are trading 'ex-rights' (ex tegningsretter) as of a specific date. It refers to a previous announcement and does not contain the full financial report or the actual capital change details, but rather serves as a market notification regarding the trading status of the shares. This fits the definition of a general regulatory announcement.
2010-05-19 Norwegian
Minutes from Extraordinary General Meeting.pdf (Att: 260745)
Declaration of Voting Results & Voting Rights Announcements Classification · 78% confidence The document is the official minutes (protocol) from an extraordinary general meeting, recording the agenda, resolutions, and unanimous shareholder votes specifically on a capital increase. This aligns with a Declaration of Voting Results & Voting Rights Announcement (DVA), which covers official results from shareholder votes at any general meeting.
2010-05-18 Norwegian

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.